Probabilistic medicine: a pre-emptive approach is needed for cancer therapeutic risk mitigation.

Authors :: Hicks JK
McLeod HL
Source :: Biomarkers in medicine [Biomark Med] 2019 Aug; Vol. 13 (12), pp. 987-990. Date of Electronic Publication: 2019 Aug 06.
Publication Year :: 2019

Subjects :: Antineoplastic Agents adverse effects
Antineoplastic Agents therapeutic use
Biomarkers, Tumor genetics
Biomarkers, Tumor metabolism
Humans
Mutation
Neoplasms genetics
Neoplasms metabolism
Neoplasms mortality
Neoplasms therapy
Precision Medicine

Full Text Access

Tools